Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026)
Insight Molecular Diagnostics (IMDX) posted Other Working Capital Changes of -$83000.0 for Q1 2026, down 315.0% sequentially from -$20000.0 in Q4 2025, and down 176.67% YoY from $108260.9 in Q1 2025.
Insight Molecular Diagnostics (IMDX) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Insight Molecular Diagnostics has reported Other Working Capital Changes for 8 years, with the latest figure at -$83000.0 in Q1 2026.
- Quarterly Other Working Capital Changes fell 176.67% year-over-year to -$83000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$195000.0 (up 13.33% YoY) and the FY2025 annual result came in at -$142000.0, up 51.2% from the prior year.
- Other Working Capital Changes fell to -$83000.0 in Q1 2026 per IMDX's latest filing, from -$20000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $422000.0 in Q2 2022 and troughed at -$619000.0 in Q1 2023.
- A 5-year average of -$20352.9 and a median of $52000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2022 and 2023: Other Working Capital Changes jumped 281.82% in 2022, then slumped 466.67% in 2023.
- Over 5 years, Other Working Capital Changes stood at $40000.0 in 2022, then slumped by 260.0% to -$64000.0 in 2023, then slumped by 162.5% to -$168000.0 in 2024, then soared by 88.1% to -$20000.0 in 2025, then plunged by 315.0% to -$83000.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$83000.0, -$20000.0, and -$57000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -449,000.00 |
| Mar 31, 2026 | -449,000.00 |
| Mar 31, 2026 | -449,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | -65,000.00 |
| Sep 30, 2025 | -65,000.00 |
| Sep 30, 2025 | -65,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Jun 30, 2025 | 104,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Mar 31, 2025 | 85,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Dec 31, 2024 | 77,000.00 |
| Sep 30, 2024 | 303,000.00 |
| Sep 30, 2024 | 303,000.00 |